GPD2 and glioblastoma: GAM-released IL-1β can also be used to stimulate the formation of vasculogenic brain oedema in glioblastoma cells by promoting glycerol-3-phosphate dehydrogenase 2 (GPD2) phosphorylation and glycolysis, thereby accelerating tumor proliferation and growth (Lu et al., 2020).